Skip to content Skip to footer

International Cannabis Weekly: 285

February 10, 2023

Highlights

Share this story

EUROPEAN CBD MARKET SET TO BE WORTH €2.6 BILLION BY 2026

Prohibition Partners estimates that, in 2022, just under €1.7 billion worth of CBD products were sold in Europe. This figure will grow by more than 50% to just under €2.6 billion by 2026, as highlighted in The European CBD Report: Health & Wellness.

CBD oil is expected to maintain its position as the most popular CBD product in Europe over the next five years, although driven by legislative reform and consumer demand, CBD flower will continue to make inroads across the continent. The report also highlights revenue growth for public European CBD companies, an increase in consumption across the continent and positive market developments.

DOWNLOAD NOW »

STUDY SAYS 108,000 CANNABIS JOBS WILL BE CREATED THIS YEAR IN US ALONE

READ MORE »

NO MEDICAL CANNABIS DATA BEING COLLECTED BY NHS PATIENT REGISTRY IN THE UK

READ MORE »

Highlights

Share this story
Europe




Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
Upcoming Event

BUSINESS OF CANNABIS: NYC SESSIONS | THE NEXT 10 YEARS IN NEW YORK

At NYC Sessions on 23 February, we’ll be looking ahead at how the unique regulatory landscape in New York might look ten years from now, with speakers from Leafly and New York State Office of Cannabis Management.

Join us for an evening of exclusive talks, premium networking opportunities, an open bar and access to Work’n’Roll’s on-site consumption lounge.

GET TICKETS »

Highlights

Share this story
Canada

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC
  • The Japanese government is set to allow the medical use of cannabis to treat patients with incurable conditions.
  • Thailand is tightening the country’s regulations on cannabis sales, with buyers now having to show ID.
  • The Cook Islands, a self-governing country with strong ties to New Zealand, is considering legalising medical cannabis.
  • Australian medical cannabis company Medlab Clinical has been awarded an export permit for CBD/THC medicine.

Highlights

Share this story
Report

Highlights

Share this story
Africa & The Middle East
  • Flower grown by Canadian cannabis company Pure Sunfarms will be available in Israeli pharmacies this month.
  • An Israeli government order will soon be sent to legal cannabis producers asking for data on earnings.
  • New patients in Israel will not be able to receive more than 20 grams of cannabis per month.
  • Atlas Global Brands signs definitive agreement with a cannabis distributor and two cannabis pharmacies in Israel.

     

 

Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.